Skip to main content
Article thumbnail
Location of Repository

Decreased T cell reactivity to Epstein–Barr virus infected lymphoblastoid cell lines in multiple sclerosis

By M P Pender, P A Csurhes, A Lenarczyk, C M M Pfluger and S R Burrows
Topics: Research Papers
Publisher: BMJ Publishing Group
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2005). Immunology of multiple sclerosis. Annu Rev Immunol
  2. (2007). Immunology of multiple sclerosis. Curr Allergy Asthma Rep
  3. Environmental risk factors for multiple sclerosis. Part I: The role of infection.
  4. High seroprevalence of Epstein–Barr virus in children with multiple sclerosis.
  5. Epstein–Barr virus: exploiting the immune system.
  6. (2003). Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. Trends Immunol
  7. Dysregulated Epstein–Barr virus infection in the multiple sclerosis brain.
  8. (1988). T-cell-mediated suppression of Epstein–Barr virusinduced B lymphocyte activation in multiple sclerosis. Clin Immunol Immunopathol
  9. (2003). Altered CD8 + T cell responses to selected Epstein–Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin Exp Immunol
  10. Frequency analysis of HLA-B7-restricted Epstein–Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.
  11. (2008). Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
  12. (2006). Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
  13. CD8 + immunodominance among Epstein–Barr virus lytic cycle antigens directly reflects the efficiency of antigen presentation in lytically infected cells.
  14. The immunogenicity of a viral cytotoxic T cell epitope is controlled by its MHC-bound conformation.
  15. (2005). Diagnostic criteria for multiple sclerosis:
  16. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS).
  17. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.
  18. (1995). T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
  19. (1997). Cytotoxic CD8 + T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts. Immunodominance is elicited by a peptide epitope that is presented at low levels in vitro.
  20. Application of the ELISPOT assay to the characterization of CD8 + responses to Epstein–Barr virus antigens.
  21. (2004). Genes in the HLA class I region may contribute to the HLA class II-associated genetic susceptibility to multiple sclerosis. Tissue Antigens
  22. (1995). Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein–Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
  23. (1996). Epitope focusing in the primary cytotoxic T cell response to Epstein–Barr virus and its relationship to T cell memory.
  24. Correlation of blood T cell and antibody reactivity to myelin proteins with HLA type and lesion localization in multiple sclerosis.
  25. Identification of Epstein–Barr virus proteins as putative targets of the immune response in multiple sclerosis.
  26. (1985). Epstein–Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis.
  27. (1985). Increased prevalence and titer of Epstein–Barr virus antibodies in patients with multiple sclerosis.
  28. Epstein–Barr virus antibodies and risk of multiple sclerosis: a prospective study.
  29. An altered immune response to Epstein–Barr virus in multiple sclerosis: a prospective study.
  30. Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis.
  31. T cells and viral persistence: lessons from diverse infections.
  32. (1996). Non-linear dynamics for clinicians: chaos theory, fractals, and complexity at the bedside. Lancet
  33. Complex systems.
  34. Selective accumulation of virus-specific CD8 + T cells with unique homing phenotype within the human bone marrow. Blood 2008;112:3293–302.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.